Physician profile
Thomas E Gustafson
NPI 1164492096
$3,416.92
in general payments reported to CMS, 2019-2025
15 companies · $626 in 2025
The $626 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $459 · 2021: $428 · 2022: $397 · 2023: $319 · 2024: $736 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,654 · Entertainment: $26.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.93 |
| Entertainment | $26.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,144.37 | 2019-2025 | Myday Contact Lens, Biofinity Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $885.36 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $417.17 | 2019-2021 | |
| Alcon Vision LLC | $323.21 | 2021-2025 | Tryptyr, Dailies Total1, Precision7 |
| Amgen INC. | $135.45 | 2024 | Tepezza |
| Biotissue Holdings INC. | $89.98 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $85.75 | 2020-2022 | |
| Abb Con-Cise Optical Group LLC | $72.09 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $64.92 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $62.47 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $32.76 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $31.98 | 2022 | |
| Optos, INC. | $26.66 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tearlab Corp | $23.97 | 2024 | Scoutpro Osmolarity System |
| Allergan, INC. | $20.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gustafson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.